Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
JAMA
    January 2025
  1. HUNTER N, Hurvitz S
    Where Did the Passion Go?-Rethinking Adjuvant Immune Therapy for Triple-Negative Breast Cancer.
    JAMA. 2025 Jan 30. doi: 10.1001/jama.2024.26811.
    >> Share

  2. IGNATIADIS M, Bailey A, McArthur H, El-Abed S, et al
    Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.
    JAMA. 2025 Jan 30. doi: 10.1001/jama.2024.26886.
    >> Share

    December 2024
  3. JOENSUU H
    Neoadjuvant Camrelizumab for Triple-Negative Breast Cancer.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.25927.
    >> Share

  4. CHEN L, Li H, Zhang H, Yang H, et al
    Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.23560.
    >> Share

    November 2024
  5. ANDERER S
    ACOG Now Recommends Breast Cancer Screenings Start at Age 40.
    JAMA. 2024 Nov 15. doi: 10.1001/jama.2024.23048.
    >> Share

  6. ANDERER S
    Study: BMI May Underestimate Obesity-Linked Breast Cancer Risk.
    JAMA. 2024 Nov 15. doi: 10.1001/jama.2024.23049.
    >> Share

  7. ORRALL A
    Breast Cancer Incidence Still Rising Despite Decline in Death Rates.
    JAMA. 2024 Nov 1. doi: 10.1001/jama.2024.22056.
    >> Share

    October 2024
  8. MORCH LS, Meaidi A, Corn G, Hargreave M, et al
    Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems.
    JAMA. 2024 Oct 16. doi: 10.1001/jama.2024.18575.
    >> Share

    September 2024
  9. THORAT MA, Cuzick J, Chan AT
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15497.
    >> Share

  10. PETRELLI F, Ghidini A
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15491.
    >> Share

  11. LI C, He J, Liang W
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15488.
    >> Share

  12. SUN R, Wei LJ
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15494.
    >> Share

  13. CHEN WY, Ballman KV, Holmes MD
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer-Reply.
    JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.15500.
    >> Share

  14. RYAN CE, Fasaye GA, Gallanis AF, Gamble LA, et al
    Germline CDH1 Variants and Lifetime Cancer Risk.
    JAMA. 2024;332:722-729.
    >> Share

    August 2024
  15. HARRIS E
    More Data About Risks, Benefits Might Change Breast Cancer Screening Choice.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13777.
    >> Share

    July 2024
  16. LEON-FERRE RA, Salgado R, Jonas SF
    Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer-Reply.
    JAMA. 2024 Jul 3. doi: 10.1001/jama.2024.10483.
    >> Share

  17. TU H, Zhang Y, You Z
    Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer.
    JAMA. 2024 Jul 3. doi: 10.1001/jama.2024.10480.
    >> Share

    June 2024
  18. RUBIN R
    Despite New Recommendations, the Debate Over Mammography Guidelines Continues.
    JAMA. 2024;331:1877-1879.
    >> Share

    May 2024
  19. MANSON JE, Crandall CJ, Rossouw JE, Chlebowski RT, et al
    The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    JAMA. 2024;331:1748-1760.
    >> Share

  20. MANDELBLATT JS, Mainor C, Hudson BI
    The Aspirin Conundrum-Navigating Negative Results, Age, Aging Dynamics, and Equity.
    JAMA. 2024;331:1709-1711.
    >> Share

  21. HARRIS E
    Young Patients Without Genetic Risk Have Low Chance of Second Breast Cancer.
    JAMA. 2024 May 3. doi: 10.1001/jama.2024.6734.
    >> Share

    April 2024
  22. TRENTHAM-DIETZ A, Chapman CH, Jayasekera J, Lowry KP, et al
    Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2023.24766.
    >> Share

  23. NICHOLSON WK, Silverstein M, Wong JB, Barry MJ, et al
    Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.5534.
    >> Share

  24. HENDERSON JT, Webber EM, Weyrich MS, Miller M, et al
    Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2023.25844.
    >> Share


  25. Screening for Breast Cancer.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.5535.
    >> Share

  26. ELMORE JG, Lee CI
    Toward More Equitable Breast Cancer Outcomes.
    JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.6052.
    >> Share

  27. CHEN WY, Ballman KV, Partridge AH, Hahn OM, et al
    Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.
    JAMA. 2024 Apr 29:e244840. doi: 10.1001/jama.2024.4840.
    >> Share

  28. CASWELL-JIN JL, Kurian AW, Plevritis SK
    US Breast Cancer Mortality-Reply.
    JAMA. 2024 Apr 25. doi: 10.1001/jama.2024.5482.
    >> Share

  29. JATOI I
    US Breast Cancer Mortality.
    JAMA. 2024 Apr 25. doi: 10.1001/jama.2024.5479.
    >> Share

  30. NAROD SA
    Breast Cancer and Pregnancy in Young BRCA Carriers.
    JAMA. 2024;331:1233-1234.
    >> Share

  31. BLONDEAUX E, Partridge AH, Lambertini M
    Breast Cancer and Pregnancy in Young BRCA Carriers-Reply.
    JAMA. 2024;331:1234.
    >> Share

  32. LEON-FERRE RA, Jonas SF, Salgado R, Loi S, et al
    Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
    JAMA. 2024;331:1135-1144.
    >> Share

    January 2024
  33. WHEELER SB, Rocque G, Basch E
    Benefits of Breast Cancer Screening and Treatment on Mortality.
    JAMA. 2024;331:199-200.
    >> Share

  34. CASWELL-JIN JL, Sun LP, Munoz D, Lu Y, et al
    Analysis of Breast Cancer Mortality in the US-1975 to 2019.
    JAMA. 2024;331:233-241.
    >> Share

    December 2023
  35. LAMBERTINI M, Blondeaux E, Agostinetto E, Hamy AS, et al
    Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
    JAMA. 2023 Dec 7. doi: 10.1001/jama.2023.25463.
    >> Share

    September 2023
  36. HARRIS E
    Air Pollution Tied With Increased Chance of Breast Cancer.
    JAMA. 2023 Sep 27. doi: 10.1001/jama.2023.18745.
    >> Share

    August 2023
  37. HARRIS E
    Breast Cancer Overdiagnosis Common Among Older Women.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.13935.
    >> Share

    July 2023
  38. KURIAN AW, Abrahamse P, Furgal A, Ward KC, et al
    Germline Genetic Testing After Cancer Diagnosis.
    JAMA. 2023;330:43-51.
    >> Share

    June 2023
  39. HARRIS E
    Most Women With Early Invasive Breast Cancer Survive.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10741.
    >> Share

    May 2023
  40. HARRIS E
    Pausing Endocrine Therapy for Pregnancy After Breast Cancer Found Safe.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8659.
    >> Share

    March 2023
  41. HARRIS E
    Study: Breast Radiotherapy Does Not Improve Survival in Older Patients.
    JAMA. 2023;329:874.
    >> Share

    January 2023
  42. KRESSIN NR, Slanetz PJ, Gunn CM
    Ensuring Clarity and Understandability of the FDA's Breast Density Notifications.
    JAMA. 2023;329:121-122.
    >> Share

    October 2022
  43. SLOMSKI A
    Fertility Preservation After Breast Cancer Diagnosis.
    JAMA. 2022;328:1289.
    >> Share

    September 2022
  44. LARKIN HD
    First Therapy Targeting ERBB2-Low Breast Cancer Approved.
    JAMA. 2022;328:819.
    >> Share

    July 2022
  45. SWAIN M, Jeudy M
    Breast Masses in Biological Females.
    JAMA. 2022;328:294-295.
    >> Share

    June 2022
  46. KERLIKOWSKE K, Su YR, Sprague BL, Tosteson ANA, et al
    Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.
    JAMA. 2022;327:2220-2230.
    >> Share

  47. FRIEDEWALD SM, Grimm LJ
    Digital Breast Tomosynthesis and Detection of Interval Invasive and Advanced Breast Cancers.
    JAMA. 2022;327:2198-2200.
    >> Share

  48. SLOMSKI A
    Greater Well-being After Breast Conservation Surgery vs Mastectomy.
    JAMA. 2022;327:2066.
    >> Share

    May 2022
  49. GOODWIN PJ, Chen BE, Gelmon KA, Whelan TJ, et al
    Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
    JAMA. 2022;327:1963-1973.
    >> Share

    April 2022
  50. SLOMSKI A
    Exercise Improves Shoulder Function After Breast Cancer Surgery.
    JAMA. 2022;327:1539.
    >> Share

  51. SURAN M
    Stagnant US Mammography Rates and the Influence of COVID-19.
    JAMA. 2022 Apr 20. pii: 2791573. doi: 10.1001/jama.2022.4295.
    >> Share

    January 2022
  52. HAHN EE, Munoz-Plaza CE, Pounds D, Lyons LJ, et al
    Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2022;327:41-49.
    >> Share

    December 2021
  53. LAM DL, Flanagan MR
    Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
    JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.
    >> Share

    October 2021
  54. VAN DYK K, Ganz PA
    Cancer-Related Cognitive Impairment in Patients With a History of Breast Cancer.
    JAMA. 2021 Oct 15. pii: 2785382. doi: 10.1001/jama.2021.13309.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016